The Role of Transgenic Livestock in the Treatment of Human Disease


Task Force Chair

Carol Keefer

Task Force Author(s)

Jerry Pommer
James Robl

Task Force Reviewers

John Matheson
John Phillips
Bruce Watkins

Task Force Board Liaison

Lyle Vogel
Issue Papers
Free (Members)
Free (Non-Members)
PDF Download:
Free (Members)
Free (Non-Members)

PART 6, "ANIMAL AGRICULTURE'S FUTURE THROUGH BIOTECHNOLOGY."This paper describes the potential for transgenic livestock to advance the development of new medications for the treatment of human disease.Two techniques discussed in this paper are the predominant methods used to produce transgenic livestock, pronuclear microinjection and somatic cell nuclear transfer (SCNT).The paper offers a brief overview of current production methods and challenges, and addresses economic, regulatory, and societal factors that impact the commercialization of products and treatments derived from transgenic animals.An appendix provides an in-depth description of the SCNT methodology.Chair: Carol L. Keefer, University of Maryland, College Park. IP 35, May 2007, 12 pp., FREE. Available online ( AND in print (515-292-2125; fee for shipping/handling).
(Keywords: Biotechnology, GMO, transgenic)


Cart Icon